Cargando…

High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma

Detalles Bibliográficos
Autores principales: Aoki, T, Shimada, K, Suzuki, R, Izutsu, K, Tomita, A, Maeda, Y, Takizawa, J, Mitani, K, Igarashi, T, Sakai, K, Miyazaki, K, Mihara, K, Ohmachi, K, Nakamura, N, Takasaki, H, Kiyoi, H, Nakamura, S, Kinoshita, T, Ogura, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735068/
https://www.ncbi.nlm.nih.gov/pubmed/26636287
http://dx.doi.org/10.1038/bcj.2015.101
_version_ 1782413010400182272
author Aoki, T
Shimada, K
Suzuki, R
Izutsu, K
Tomita, A
Maeda, Y
Takizawa, J
Mitani, K
Igarashi, T
Sakai, K
Miyazaki, K
Mihara, K
Ohmachi, K
Nakamura, N
Takasaki, H
Kiyoi, H
Nakamura, S
Kinoshita, T
Ogura, M
author_facet Aoki, T
Shimada, K
Suzuki, R
Izutsu, K
Tomita, A
Maeda, Y
Takizawa, J
Mitani, K
Igarashi, T
Sakai, K
Miyazaki, K
Mihara, K
Ohmachi, K
Nakamura, N
Takasaki, H
Kiyoi, H
Nakamura, S
Kinoshita, T
Ogura, M
author_sort Aoki, T
collection PubMed
description
format Online
Article
Text
id pubmed-4735068
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-47350682016-02-17 High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma Aoki, T Shimada, K Suzuki, R Izutsu, K Tomita, A Maeda, Y Takizawa, J Mitani, K Igarashi, T Sakai, K Miyazaki, K Mihara, K Ohmachi, K Nakamura, N Takasaki, H Kiyoi, H Nakamura, S Kinoshita, T Ogura, M Blood Cancer J Letter to the Editor Nature Publishing Group 2015-12 2015-12-04 /pmc/articles/PMC4735068/ /pubmed/26636287 http://dx.doi.org/10.1038/bcj.2015.101 Text en Copyright © 2015 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Letter to the Editor
Aoki, T
Shimada, K
Suzuki, R
Izutsu, K
Tomita, A
Maeda, Y
Takizawa, J
Mitani, K
Igarashi, T
Sakai, K
Miyazaki, K
Mihara, K
Ohmachi, K
Nakamura, N
Takasaki, H
Kiyoi, H
Nakamura, S
Kinoshita, T
Ogura, M
High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma
title High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma
title_full High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma
title_fullStr High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma
title_full_unstemmed High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma
title_short High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma
title_sort high-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large b-cell lymphoma
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735068/
https://www.ncbi.nlm.nih.gov/pubmed/26636287
http://dx.doi.org/10.1038/bcj.2015.101
work_keys_str_mv AT aokit highdosechemotherapyfollowedbyautologousstemcelltransplantationforrelapsedrefractoryprimarymediastinallargebcelllymphoma
AT shimadak highdosechemotherapyfollowedbyautologousstemcelltransplantationforrelapsedrefractoryprimarymediastinallargebcelllymphoma
AT suzukir highdosechemotherapyfollowedbyautologousstemcelltransplantationforrelapsedrefractoryprimarymediastinallargebcelllymphoma
AT izutsuk highdosechemotherapyfollowedbyautologousstemcelltransplantationforrelapsedrefractoryprimarymediastinallargebcelllymphoma
AT tomitaa highdosechemotherapyfollowedbyautologousstemcelltransplantationforrelapsedrefractoryprimarymediastinallargebcelllymphoma
AT maeday highdosechemotherapyfollowedbyautologousstemcelltransplantationforrelapsedrefractoryprimarymediastinallargebcelllymphoma
AT takizawaj highdosechemotherapyfollowedbyautologousstemcelltransplantationforrelapsedrefractoryprimarymediastinallargebcelllymphoma
AT mitanik highdosechemotherapyfollowedbyautologousstemcelltransplantationforrelapsedrefractoryprimarymediastinallargebcelllymphoma
AT igarashit highdosechemotherapyfollowedbyautologousstemcelltransplantationforrelapsedrefractoryprimarymediastinallargebcelllymphoma
AT sakaik highdosechemotherapyfollowedbyautologousstemcelltransplantationforrelapsedrefractoryprimarymediastinallargebcelllymphoma
AT miyazakik highdosechemotherapyfollowedbyautologousstemcelltransplantationforrelapsedrefractoryprimarymediastinallargebcelllymphoma
AT miharak highdosechemotherapyfollowedbyautologousstemcelltransplantationforrelapsedrefractoryprimarymediastinallargebcelllymphoma
AT ohmachik highdosechemotherapyfollowedbyautologousstemcelltransplantationforrelapsedrefractoryprimarymediastinallargebcelllymphoma
AT nakamuran highdosechemotherapyfollowedbyautologousstemcelltransplantationforrelapsedrefractoryprimarymediastinallargebcelllymphoma
AT takasakih highdosechemotherapyfollowedbyautologousstemcelltransplantationforrelapsedrefractoryprimarymediastinallargebcelllymphoma
AT kiyoih highdosechemotherapyfollowedbyautologousstemcelltransplantationforrelapsedrefractoryprimarymediastinallargebcelllymphoma
AT nakamuras highdosechemotherapyfollowedbyautologousstemcelltransplantationforrelapsedrefractoryprimarymediastinallargebcelllymphoma
AT kinoshitat highdosechemotherapyfollowedbyautologousstemcelltransplantationforrelapsedrefractoryprimarymediastinallargebcelllymphoma
AT oguram highdosechemotherapyfollowedbyautologousstemcelltransplantationforrelapsedrefractoryprimarymediastinallargebcelllymphoma